Steve Jobs's cancer may have recurred: doctors

By Anupreeta Das

SAN FRANCISCO (Reuters) - Pancreatic cancer experts say they are puzzled by what is ailing Apple Inc Chief Executive Steve Jobs, because it is not clear how serious his health problems are or how directly they relate to his bout with cancer.

Last week, Jobs said he had an easily treatable "hormonal imbalance" that was robbing his body of the proteins it needs. Then, on Wednesday, the 53-year-old CEO said his problems were "more complex" than originally thought, and he would take a medical leave of absence for six months.

Doctors who have not treated Jobs say they can only speculate without hard information, but they said the tumor he was treated for in 2004 could have spread to another organ or resurfaced in the pancreas, requiring surgery or other treatment.

Jobs could also be coping with side effects of that surgery that can be treated easily, they said.

In 2004, Jobs was treated for a rare type of pancreatic cancer called an islet-cell, or neuroendocrine, tumor. Such tumors can be benign or malignant, but they usually grow slowly and are far less deadly than most pancreatic tumors.

The American Cancer Society estimates that 37,680 Americans get pancreatic cancer each year, but few get islet-cell tumors of the kind Jobs had. The tumors are easily removed surgically but recur in roughly half of patients, said Dr. Roderich Schwarz, a cancer surgeon at the University of Texas Southwestern Medical Center in Dallas.

Dr. Clay Semenkovich, an endocrinologist at Washington University in St. Louis, said in a telephone interview, "(Jobs) may have a new mass that's substantially altering his physiology and causing him to lose weight."

WEIGHT LOSS